| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Rakesh Jain | Q7286601 |
| John D Martin | Q57032133 | ||
| Dai Fukumura | Q88059338 | ||
| P2093 | author name string | Dan G Duda | |
| Yves Boucher | |||
| P2860 | cites work | Molecular Pathways Linking Inflammation and Cancer | Q22241330 |
| Genes expressed in human tumor endothelium | Q24290105 | ||
| Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
| Openings between defective endothelial cells explain tumor vessel leakiness | Q24681507 | ||
| Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer | Q43787483 | ||
| Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. | Q44235706 | ||
| Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy | Q44240071 | ||
| Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer | Q44430058 | ||
| Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial. | Q45088794 | ||
| Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer. | Q46055974 | ||
| Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. | Q46127843 | ||
| CANCER. Tumor angiogenesis, from foe to friend | Q46851713 | ||
| Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. | Q47654612 | ||
| Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study | Q47746681 | ||
| Lack of correlation between expression of HIF-1alpha protein and oxygenation status in identical tissue areas of squamous cell carcinomas of the uterine cervix | Q47941165 | ||
| Evaluation of tumor stiffness by elastography is predictive for pathologic complete response to neoadjuvant chemotherapy in patients with breast cancer. | Q47941822 | ||
| Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications | Q48136888 | ||
| Elastic moduli of normal and pathological human breast tissues: an inversion-technique-based investigation of 169 samples | Q48412046 | ||
| Hypoxic prostate/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings | Q49028556 | ||
| A novel population of local pericyte precursor cells in tumor stroma that require Notch signaling for differentiation. | Q50961698 | ||
| Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. | Q51056982 | ||
| Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. | Q51728958 | ||
| Effect of transvascular fluid exchange on pressure-flow relationship in tumors: a proposed mechanism for tumor blood flow heterogeneity. | Q52302546 | ||
| Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugs. | Q53179408 | ||
| Onset of abnormal blood and lymphatic vessel function and interstitial hypertension in early stages of carcinogenesis. | Q53347766 | ||
| Tumor-associated endothelial cells with cytogenetic abnormalities. | Q54692960 | ||
| Mechanical induction of the tumorigenic β-catenin pathway by tumour growth pressure. | Q55059234 | ||
| Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. | Q55481775 | ||
| Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression | Q57742732 | ||
| Mammographic Density and the Risk and Detection of Breast Cancer | Q59545042 | ||
| A chemokine receptor antagonist inhibits experimental breast tumor growth | Q61819228 | ||
| A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer | Q62392184 | ||
| Transmural Coupling of Fluid Flow in Microcirculatory Network and Interstitium in Tumors | Q62470814 | ||
| Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation | Q66939542 | ||
| Viscous resistance to blood flow in solid tumors: effect of hematocrit on intratumor blood viscosity | Q69626867 | ||
| Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma | Q71102409 | ||
| Low pH leads to sister-chromatid exchanges and chromosomal aberrations, and its clastogenicity is S-dependent | Q72243806 | ||
| Extracellular pH distribution in human tumours | Q72334607 | ||
| Noninvasive measurement of interstitial pH profiles in normal and neoplastic tissue using fluorescence ratio imaging microscopy | Q72710485 | ||
| Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation | Q73034285 | ||
| Role of extracellular matrix assembly in interstitial transport in solid tumors | Q73793048 | ||
| Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer | Q74093456 | ||
| Tumor induction of VEGF promoter activity in stromal cells | Q77349243 | ||
| Lymphatic metastasis in the absence of functional intratumor lymphatics | Q78009338 | ||
| Identification of fibroblast heterogeneity in the tumor microenvironment | Q79360133 | ||
| Inhibitory effect of tumor cell-derived lactic acid on human T cells | Q79666516 | ||
| Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy | Q83739387 | ||
| Anti-vascular endothelial growth factor therapy in breast cancer: game over? | Q85883923 | ||
| The inhibition of renin-angiotensin system in advanced pancreatic cancer: an exploratory analysis in 349 patients | Q85965147 | ||
| Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer | Q35830110 | ||
| Cancer stem cells: impact, heterogeneity, and uncertainty | Q35857599 | ||
| A subset of myofibroblastic cancer-associated fibroblasts regulate collagen fiber elongation, which is prognostic in multiple cancers | Q35881485 | ||
| Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer | Q35920843 | ||
| Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner | Q36016318 | ||
| Angiotensin system inhibitors and survival outcomes in patients with metastatic renal cell carcinoma. | Q36051199 | ||
| Metformin use is associated with better survival of diabetic patients with pancreatic cancer | Q36053323 | ||
| Paclitaxel decreases the interstitial fluid pressure and improves oxygenation in breast cancers in patients treated with neoadjuvant chemotherapy: clinical implications | Q36073411 | ||
| Remodeling of extracellular matrix due to solid stress accumulation during tumor growth | Q36134774 | ||
| Molecular mechanisms mediating metastasis of hypoxic breast cancer cells | Q36254122 | ||
| Investigation of the Lack of Angiogenesis in the Formation of Lymph Node Metastases | Q36294948 | ||
| Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients. | Q36306066 | ||
| Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy | Q36378276 | ||
| Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts | Q36379569 | ||
| Mouse embryonic fibroblasts exhibit extensive developmental and phenotypic diversity | Q36459354 | ||
| Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment | Q36477445 | ||
| Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer | Q36550798 | ||
| Balancing forces: architectural control of mechanotransduction | Q36588911 | ||
| Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis | Q36671716 | ||
| Regulation of DNA repair in hypoxic cancer cells | Q36784378 | ||
| Detection and characterization of tumor hypoxia using pO2 histography | Q36834948 | ||
| Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis | Q36895504 | ||
| A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation | Q36904098 | ||
| A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response | Q36905046 | ||
| Transforming growth factor-beta and the immune response: implications for anticancer therapy | Q36944384 | ||
| Coevolution of solid stress and interstitial fluid pressure in tumors during progression: implications for vascular collapse | Q36986223 | ||
| PlGF/VEGFR-1 Signaling Promotes Macrophage Polarization and Accelerated Tumor Progression in Obesity | Q37014054 | ||
| Tumor stroma and regulation of cancer development | Q37014752 | ||
| The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy. | Q37081132 | ||
| Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. | Q37084096 | ||
| The Lymphatic System in Disease Processes and Cancer Progression | Q37099065 | ||
| Effects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progression | Q37106787 | ||
| Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments | Q37111862 | ||
| Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progression | Q26785362 | ||
| Genetic instability in the tumor microenvironment: a new look at an old neighbor | Q26801374 | ||
| Orchestrating the Tumor Microenvironment to Improve Survival for Patients With Pancreatic Cancer: Normalization, Not Destruction | Q26801834 | ||
| The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? | Q26824147 | ||
| Neutralizing tumor-promoting chronic inflammation: a magic bullet? | Q26830931 | ||
| Mechanical stress impairs mitosis progression in multi-cellular tumor spheroids | Q27301931 | ||
| Optical volume and mass measurements show that mammalian cells swell during mitosis. | Q27309271 | ||
| Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages | Q27348974 | ||
| Micro-environmental mechanical stress controls tumor spheroid size and morphology by suppressing proliferation and inducing apoptosis in cancer cells | Q27353992 | ||
| Epithelial-mesenchymal transitions in development and disease | Q27860630 | ||
| Role of TGFβ in regulation of the tumor microenvironment and drug delivery (review) | Q28081170 | ||
| Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia | Q28085029 | ||
| Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma | Q28181979 | ||
| RETRACTED: Lysyl oxidase is essential for hypoxia-induced metastasis | Q28236828 | ||
| Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance | Q28269714 | ||
| Lysyl oxidase mediates hypoxic control of metastasis | Q28271667 | ||
| Why do cancers have high aerobic glycolysis? | Q28290710 | ||
| Signatures of mutational processes in human cancer | Q29547191 | ||
| Molecular mechanisms and clinical applications of angiogenesis | Q29547314 | ||
| Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion | Q29547317 | ||
| Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy | Q29547379 | ||
| Microenvironmental regulation of metastasis | Q29547660 | ||
| A perivascular niche for brain tumor stem cells | Q29614276 | ||
| Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy | Q29614312 | ||
| CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans | Q29614348 | ||
| Molecular regulation of vessel maturation | Q29614540 | ||
| Targeting hypoxia in cancer therapy | Q29615491 | ||
| The causes and consequences of genetic heterogeneity in cancer evolution | Q29615848 | ||
| Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma | Q29616287 | ||
| Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine | Q29616728 | ||
| The extracellular matrix: not just pretty fibrils | Q29617251 | ||
| VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia | Q29617501 | ||
| Influence of tumour micro-environment heterogeneity on therapeutic response | Q29617534 | ||
| Metabolic reprogramming: a cancer hallmark even warburg did not anticipate | Q29617612 | ||
| Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis | Q29617644 | ||
| The extracellular matrix: a dynamic niche in cancer progression | Q29617793 | ||
| Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy | Q29618033 | ||
| Regulation of angiogenesis by hypoxia: role of the HIF system | Q29619187 | ||
| Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells | Q29619848 | ||
| Intra-tumour heterogeneity: a looking glass for cancer? | Q29620149 | ||
| Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy | Q30388746 | ||
| A tense situation: forcing tumour progression | Q37112264 | ||
| Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy | Q37161504 | ||
| Hypoxia triggers hedgehog-mediated tumor-stromal interactions in pancreatic cancer | Q37195134 | ||
| Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells | Q37221453 | ||
| Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels | Q37250548 | ||
| Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer | Q37295258 | ||
| Longitudinal and multimodal in vivo imaging of tumor hypoxia and its downstream molecular events | Q37310720 | ||
| Combining two strategies to improve perfusion and drug delivery in solid tumors | Q37319733 | ||
| Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome. | Q37331743 | ||
| Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation. | Q37340643 | ||
| Can shear-wave elastography predict response to neoadjuvant chemotherapy in women with invasive breast cancer? | Q37352596 | ||
| BRCA1 tumours correlate with a HIF-1alpha phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression | Q37400573 | ||
| Multiwell stiffness assay for the study of cell responsiveness to cytotoxic drugs | Q37600858 | ||
| Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in mice. | Q37666058 | ||
| Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway | Q37723067 | ||
| Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity | Q37734258 | ||
| Pericytes and vessel maturation during tumor angiogenesis and metastasis | Q37764322 | ||
| Oxygen in Stem Cell Biology: A Critical Component of the Stem Cell Niche | Q37777514 | ||
| Glioblastoma, cancer stem cells and hypoxia | Q37807468 | ||
| Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases | Q37883025 | ||
| Interfering with pH regulation in tumours as a therapeutic strategy | Q37933052 | ||
| The lymphatic vasculature in disease | Q37953774 | ||
| From stem cells to cancer stem cells: HIF takes the stage | Q37980560 | ||
| Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies. | Q37995276 | ||
| Lymphatic vessels in health and disease | Q38064829 | ||
| Markers of response for the antiangiogenic agent bevacizumab | Q38080828 | ||
| HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression | Q38112399 | ||
| Deciphering and reversing tumor immune suppression. | Q38124437 | ||
| Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology | Q38128383 | ||
| Hypoxia in tumors: pathogenesis-related classification, characterization of hypoxia subtypes, and associated biological and clinical implications | Q38204334 | ||
| Tumor-associated macrophages: from mechanisms to therapy | Q38230880 | ||
| Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies | Q38236895 | ||
| Using tumour phylogenetics to identify the roots of metastasis in humans. | Q38324281 | ||
| Tumorigenesis: it takes a village | Q38544200 | ||
| Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment | Q38567779 | ||
| Dynamic regulation of stem cell specification and maintenance by hypoxia-inducible factors | Q38628352 | ||
| Targeting Transcriptional and Epigenetic Reprogramming in Stromal Cells in Fibrosis and Cancer | Q38708376 | ||
| Antiangiogenic therapy in oncology: current status and future directions | Q38725587 | ||
| Acidosis differently modulates the inflammatory program in monocytes and macrophages | Q38825054 | ||
| Stress-mediated progression of solid tumors: effect of mechanical stress on tissue oxygenation, cancer cell proliferation, and drug delivery | Q38875758 | ||
| Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread | Q38920450 | ||
| Tumor vessel normalization by chloroquine independent of autophagy. | Q38966643 | ||
| LIF mediates proinvasive activation of stromal fibroblasts in cancer | Q38992217 | ||
| Bevacizumab-induced normalization of blood vessels in tumors hampers antibody uptake | Q39167500 | ||
| Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells. | Q39507131 | ||
| Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha | Q39635625 | ||
| Determinants of tumor blood flow: a review | Q39636842 | ||
| A seven-gene set associated with chronic hypoxia of prognostic importance in hepatocellular carcinoma | Q39686498 | ||
| Sonic hedgehog promotes desmoplasia in pancreatic cancer | Q39933626 | ||
| Acidosis induces multi-drug resistance in rat prostate cancer cells (AT1) in vitro and in vivo by increasing the activity of the p-glycoprotein via activation of p38. | Q39946856 | ||
| The histological structure of some human lung cancers and the possible implications for radiotherapy | Q39979244 | ||
| Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity | Q40013431 | ||
| Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix. | Q40458180 | ||
| Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. | Q40479307 | ||
| Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells | Q40515728 | ||
| Extracellular acidification alters lysosomal trafficking in human breast cancer cells | Q40589703 | ||
| Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism | Q40738901 | ||
| Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction | Q40964604 | ||
| Gene Expression Signatures Predictive of Bevacizumab/Erlotinib Therapeutic Benefit in Advanced Nonsquamous Non-Small Cell Lung Cancer Patients (SAKK 19/05 trial). | Q41001434 | ||
| Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse | Q41110114 | ||
| Acidic pH enhances the invasive behavior of human melanoma cells | Q41225356 | ||
| Tissue oxygen distribution in head and neck cancer patients | Q41616158 | ||
| Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model | Q42573981 | ||
| Compression of pancreatic tumor blood vessels by hyaluronan is caused by solid stress and not interstitial fluid pressure | Q42655521 | ||
| Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene | Q42739835 | ||
| Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling. | Q43639734 | ||
| Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. | Q34429912 | ||
| Scaling rules for diffusive drug delivery in tumor and normal tissues | Q34549862 | ||
| The reprogramming of tumor stroma by HSF1 is a potent enabler of malignancy | Q34599918 | ||
| Stromal disrupting effects of nab-paclitaxel in pancreatic cancer | Q34654904 | ||
| Transdifferentiation of glioblastoma cells into vascular endothelial cells | Q34694093 | ||
| Vascular permeability, vascular hyperpermeability and angiogenesis | Q34753662 | ||
| Aligned collagen is a prognostic signature for survival in human breast carcinoma | Q34760807 | ||
| CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages | Q34995099 | ||
| Improved tumor vascularization after anti-VEGF therapy with carboplatin and nab-paclitaxel associates with survival in lung cancer | Q35062862 | ||
| Tumor mechanics and metabolic dysfunction | Q35117423 | ||
| Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: a retrospective examination | Q35219246 | ||
| CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice | Q35528287 | ||
| Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis | Q35628173 | ||
| Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion. | Q35680814 | ||
| Mechanical compression drives cancer cells toward invasive phenotype | Q35734996 | ||
| Heterogeneity of the tumor vasculature | Q35752502 | ||
| Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia | Q30399006 | ||
| Normalization of the vasculature for treatment of cancer and other diseases | Q30471456 | ||
| Gene expression profile and angiogenic marker correlates with response to neoadjuvant bevacizumab followed by bevacizumab plus chemotherapy in breast cancer | Q30484735 | ||
| A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients | Q30493217 | ||
| Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors | Q30525290 | ||
| Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization | Q30579125 | ||
| The cancer glycocalyx mechanically primes integrin-mediated growth and survival | Q30656235 | ||
| Invasive Cell Fate Requires G1 Cell-Cycle Arrest and Histone Deacetylase-Mediated Changes in Gene Expression | Q30703677 | ||
| PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation | Q33569771 | ||
| Hypermutable DNA chronicles the evolution of human colon cancer | Q33606821 | ||
| The roles of TGFβ in the tumour microenvironment | Q33630845 | ||
| Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions | Q33770680 | ||
| Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma | Q33896442 | ||
| The role of mechanical forces in tumor growth and therapy | Q33942378 | ||
| Fibroblast heterogeneity in the cancer wound | Q33964324 | ||
| Stromal response to Hedgehog signaling restrains pancreatic cancer progression | Q34002580 | ||
| Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. | Q34045380 | ||
| Glioblastoma stem-like cells give rise to tumour endothelium. | Q34151507 | ||
| Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. | Q34151513 | ||
| Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors | Q34152009 | ||
| Macrophage Expression of Hypoxia-Inducible Factor-1α Suppresses T-Cell Function and Promotes Tumor Progression | Q34168497 | ||
| Automated quantification of aligned collagen for human breast carcinoma prognosis | Q34210986 | ||
| Excessive hyaluronan production promotes acquisition of cancer stem cell signatures through the coordinated regulation of Twist and the transforming growth factor β (TGF-β)-Snail signaling axis | Q34249060 | ||
| Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy | Q34253198 | ||
| Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival | Q34269713 | ||
| Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity | Q34287934 | ||
| Pathology: cancer cells compress intratumour vessels. | Q34299753 | ||
| Acidity generated by the tumor microenvironment drives local invasion | Q34320819 | ||
| Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy | Q34354300 | ||
| Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine | Q34363486 | ||
| Tumour heterogeneity in the clinic | Q34372080 | ||
| Malignant cells facilitate lung metastasis by bringing their own soil | Q34411553 | ||
| Compressive stress inhibits proliferation in tumor spheroids through a volume limitation | Q34424203 | ||
| P2507 | corrigendum / erratum | Corrigendum: Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity | Q42360639 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoxia | Q105688 |
| heterogeneity | Q928498 | ||
| P577 | publication date | 2016-12-01 | |
| P1433 | published in | Cold Spring Harbor Perspectives in Medicine | Q21042440 |
| P1476 | title | Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity | |
| P478 | volume | 6 |
| Q90503363 | Bioactive lysolipids in cancer and angiogenesis |
| Q59812716 | Characterizing Trastuzumab-Induced Alterations in Intratumoral Heterogeneity with Quantitative Imaging and Immunohistochemistry in HER2+ Breast Cancer |
| Q64986589 | Co-administration of Shexiang Baoxin Pill and Chemotherapy Drugs Potentiated Cancer Therapy by Vascular-Promoting Strategy. |
| Q89051650 | DCE-MRI of Sunitinib-Induced Changes in Tumor Microvasculature and Hypoxia: A Study of Pancreatic Ductal Adenocarcinoma Xenografts |
| Q90446190 | DZNep inhibits Hif-1α and Wnt signalling molecules to attenuate the proliferation and invasion of BGC-823 gastric cancer cells |
| Q98177854 | Development of MicroRNAs as Potential Therapeutics against Cancer |
| Q88475926 | Differential expression of IL-6/IL-6R and MAO-A regulates invasion/angiogenesis in breast cancer |
| Q90418147 | Diffusion-Weighted MRI Is Insensitive to Changes in the Tumor Microenvironment Induced by Antiangiogenic Therapy |
| Q97536610 | Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI |
| Q90591603 | Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma |
| Q92456706 | Gluconeogenesis in cancer cells - Repurposing of a starvation-induced metabolic pathway? |
| Q57263190 | Integrative landscape of dysregulated signaling pathways of clinically distinct pancreatic cancer subtypes |
| Q38663657 | Lipophilic siRNA targets albumin in situ and promotes bioavailability, tumor penetration, and carrier-free gene silencing. |
| Q65002844 | Low‑intensity pulsed ultrasound promotes apoptosis and inhibits angiogenesis via p38 signaling‑mediated endoplasmic reticulum stress in human endothelial cells. |
| Q48269732 | M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma |
| Q87965611 | Macromolecule-Network Electrostatics Controlling Delivery of the Biotherapeutic Cell Modulator TIMP-2 |
| Q99632062 | Modulating barriers of tumor microenvironment through nanocarrier systems for improved cancer immunotherapy: a review of current status and future perspective |
| Q57484416 | Monitoring of tumor vascular normalization: the key points from basic research to clinical application |
| Q39092636 | Order Matters: The Order of Somatic Mutations Influences Cancer Evolution |
| Q50657508 | Proteasome Inhibitor-Loaded Micelles Enhance Antitumor Activity Through Macrophage Reprogramming by NF-κB Inhibition. |
| Q52615294 | Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside. |
| Q93239999 | Spatial heterogeneity of oxygenation and haemodynamics in breast cancer resolved in vivo by conical multispectral optoacoustic mesoscopy |
| Q89638587 | TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity |
| Q47722580 | Targeting Inflammation to Improve Tumor Drug Delivery |
| Q38654867 | The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer. |
| Q50077270 | Tissue Force Programs Cell Fate and Tumor Aggression |
| Q39403862 | Tumor angiogenesis and vascular normalization: alternative therapeutic targets |
| Q39388967 | Tumour-on-a-chip: microfluidic models of tumour morphology, growth and microenvironment. |
| Q90292779 | Vascularization, Oxygenation, and the Effect of Sunitinib Treatment in Pancreatic Ductal Adenocarcinoma Xenografts |
| Q64100298 | mRNA-to-protein translation in hypoxia |
| Q42360639 | Corrigendum: Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity | main subject | P921 |
Search more.